Approach Process Access Contact

Inflate Capital

A systematic trading firm. We research, validate and deploy fully algorithmic strategies across index CFDs and foreign exchange - and allocate capital only where the evidence survives scrutiny.

Scroll to discover Quantitative Research Automated Execution Risk Governance

Thousands of ideas.
One surviving path.

Who we are

Advancing systematic trading through evidence.

Inflate Capital is a quantitative trading firm. Every position we take is generated, sized and executed by rule - there is no discretionary override, no signal service, and no manual intervention in a live book.

We research strategies for our own account first. Only those that survive years of out-of-sample testing and a full forward-testing cycle are made available to external capital, either under licence or through managed allocation.

We are not a development shop. We do not build strategies to order, and we do not sell mentorship, education or trade alerts.

The advantage

What separates a real edge from a fitted curve.

Most strategies that look profitable are artefacts of the data they were built on. Our entire process is designed to find that out early, cheaply, and before capital is ever committed.

Breadth of search

Hypotheses are drawn from market microstructure, academic literature, and our own observation of order flow - then tested at scale rather than hand-picked.

Hostile validation

Every candidate is attacked: walk-forward windows, parameter neighbourhoods, transaction-cost stress, regime partitioning. Survivorship is the exception, not the outcome we design for.

Execution integrity

Strategies run on automated infrastructure with pre-trade risk checks, so live behaviour matches tested behaviour rather than drifting from it.

The process

From idea to allocated capital.

The pipeline is deliberately punitive. The large majority of ideas are eliminated before they reach a forward test, and a strategy that reaches allocation has been through every stage below without exception.

01

Idea generation

Hypotheses are sourced from market observation, published research and our own internal agenda. Each is written down as a testable claim about market behaviour before a line of code is written.

02

Systematic testing at scale

Every hypothesis is expressed as a rule set and tested across instruments, timeframes and market regimes. Thousands of variants are examined so that a result is judged against its own family, not in isolation.

03

Isolating the edge

Survivors are stripped to the mechanism that actually produces the return. If the performance cannot be attributed to a stated, economically plausible cause, it is discarded regardless of the equity curve.

04

Backtest and forward test

The isolated edge is re-tested out of sample, then run forward on live market data for a period of months. Live slippage, spread and fill behaviour are measured against modelled assumptions.

05

Capital allocation

Only after forward results agree with expectation is capital committed, sized by volatility and correlation to the existing book. Allocation is reviewed continuously and withdrawn when behaviour degrades.

By the numbers

Research volume, stated plainly.

0Hypotheses tested
0Simulation runs
0Minimum forward test
0Survival rate to live

Figures describe our research pipeline, not investment returns. Past testing results are not indicative of future performance.

Access

Two ways to work with the research.

We license what we already run, and we manage capital with it. Both routes give access to the same strategies under the same risk framework.

01 - Strategy licensing

Run our strategies on your own account

Licensed access to selected strategies, deployed on your infrastructure or ours, with defined parameters, documented risk limits and ongoing monitoring. You keep custody of your capital throughout.

02 - Managed allocation

Allocate to a managed algorithmic account

Capital is allocated across a diversified set of live strategies and managed by us within an agreed mandate. Reporting covers exposure, drawdown and attribution at the strategy level.

Trading leveraged instruments carries substantial risk of loss. Nothing on this page is an offer, a solicitation, or investment advice, and access is subject to eligibility and jurisdiction.

Engagement

Start with the evidence, not the pitch.

Qualified prospective partners receive a research dossier for the strategies under discussion: methodology, test design, forward-test results and the risk framework that governs them.

Write to trading@inflatecapital.com with your mandate, capital range and jurisdiction, and we will respond with the appropriate documentation.